Chemical inhibitors of TMEM222 can exert their effects through various pathways by targeting different enzymatic activities that are likely to be connected with the function of TMEM222. Genistein, a tyrosine kinase inhibitor, obstructs the phosphorylation process, which is essential for the activation of many proteins. If TMEM222 is associated with tyrosine phosphorylation-dependent processes, Genistein would inhibit its function by preventing this post-translational modification. Similarly, Chelerythrine, a potent inhibitor of protein kinase C (PKC), could inhibit TMEM222 by obstructing PKC-mediated phosphorylation if TMEM222 is regulated by this mechanism. LY294002 and Wortmannin, both inhibitors of phosphoinositide 3-kinases (PI3K), can block the PI3K/Akt pathway, which is a crucial signaling pathway for cell survival and metabolism. Inhibition of PI3K would impede the function of TMEM222 if it is PI3K-dependent.
Moreover, PD98059 and SB203580, which selectively inhibit mitogen-activated protein kinase kinase (MEK) and p38 MAP kinase, respectively, would inhibit TMEM222 by preventing the activation of these MAPK pathways if TMEM222 is a downstream effector. SP600125 targets c-Jun N-terminal kinase (JNK), which is involved in regulating apoptosis, and inhibition of JNK would lead to TMEM222 inhibition if there is a regulatory relationship. U73122 inhibits phospholipase C, which plays a role in intracellular signaling, and this would lead to inhibition of TMEM222 if its function is dependent on phospholipase C pathways. Gö6976 and Bisindolylmaleimide I, both PKC inhibitors, would inhibit TMEM222 if it is regulated by PKC isoforms that these inhibitors target. Okadaic Acid, a potent inhibitor of protein phosphatases PP1 and PP2A, would prevent dephosphorylation events, which could inhibit TMEM222 if its activity is dependent on a phosphorylated state maintained by these phosphatases. Lastly, Rapamycin, an mTOR inhibitor, would lead to TMEM222 inhibition by interfering with mTOR signaling if TMEM222 functions are connected to this pathway. Each chemical's action contributes to a concerted blockade of signaling and regulatory mechanisms that can inhibit the functional activity of TMEM222.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein inhibits tyrosine kinases, which could lead to the inhibition of TMEM222 if its function is associated with tyrosine phosphorylation-dependent processes. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a potent inhibitor of protein kinase C (PKC), and if TMEM222 function is regulated by PKC-mediated phosphorylation, this would result in functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits phosphoinositide 3-kinases (PI3K), and by doing so, it could inhibit TMEM222 if PI3K signaling is crucial for TMEM222 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits mitogen-activated protein kinase kinase (MEK), and if TMEM222 is regulated downstream of the MEK/ERK pathway, PD98059 would inhibit its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor and could inhibit TMEM222 function if TMEM222 activity is modulated by p38 MAPK signaling pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, and its inhibition of PI3K could lead to the inhibition of TMEM222 if TMEM222 relies on PI3K signaling for its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinase (JNK), potentially inhibiting TMEM222 if TMEM222's activity is modulated by JNK signaling. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö6976 is a selective inhibitor of PKCα and PKCβ1, and if TMEM222 is regulated by these PKC isoforms, this chemical would inhibit TMEM222 function. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor, and if PKC is involved in the regulation of TMEM222, this chemical would functionally inhibit TMEM222. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, and if these phosphatases regulate TMEM222 phosphorylation state, this would result in TMEM222 inhibition. | ||||||